Data gathering and analysis of medical conference data can provide a clear, strategic view and help the industry save time and money and align day-to-day goals with big-picture outcomes.
A growing interest in the use of RWE to help drive treatment decisions is creating excitement, and some concern. ICER has published two white papers to lay out the issues and offer some potential solutions for helping the industry move forward
The Institute for Clinical and Economic Review (ICER) published a report in March outlining a conceptual framework for developing a common approach to using RWE to make treatment decisions and reporting on benefits and potential drawbacks of this trend.
Because scientific data generation and dissemination is the core focus of Medical Affairs, the only way to measure performance and become more strategic is to look at SoSV and SoSI, precisely because they measure the effectiveness of those activities.
Impact factors reflect how broadly useful a paper or journal is to the scientific and medical communities. However, for Medical Affairs, more specialized papers may provide more valuable information, and suggest a new approach.